AbbVie : ABBV

All AbbVie Articles

606 Articles

Jon C. Ogg | Feb 8, 2014 at 8:30 AM EST

Five Quantitative Analyst Stocks With Limited Emerging Markets Exposure

In Deutsche Bank's monthly quant view research piece, the firm looks for strategies that investors can implement to limit their…

Jon C. Ogg | Dec 30, 2013 at 11:30 AM EST

Many Key Changes to Goldman Sachs Conviction Buy List for 2014

If one firm can create interest around a stock, it is Goldman Sachs. Investors have followed its Conviction Buy List…

Jon C. Ogg | Dec 7, 2013 at 8:01 AM EST

Goldman Sachs Makes Major Conviction Buy List Changes for 2014

GS.COMIt is that time of year when investors start positioning their portfolios for the year ahead. 24/7 Wall St. reviews…

Jon C. Ogg | Dec 3, 2013 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More

These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, December 3, 2013.…

Jon C. Ogg | Oct 29, 2013 at 8:30 AM EDT

Top Analyst Upgrades and Downgrades: Apple, BBVA, Kors, PotBelly and More

Jon OggWe are in the thick of earnings season, a deal was made in D.C. and stocks are challenging new…

Jon C. Ogg | Oct 16, 2013 at 11:20 AM EDT

New IPO ETF Certain to Gain Traction, More IPO ETF Competition

ThinkstockThe saying is that if there is a trading strategy, then there is an ETF strategy for that as well.…

Jon C. Ogg | Oct 9, 2013 at 8:15 AM EDT

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown…

Jon C. Ogg | Oct 2, 2013 at 12:25 PM EDT

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

ThinkstockWhen the markets go through periods of great gains, it is not uncommon to see companies start to take more…

Lee Jackson | Sep 16, 2013 at 8:45 AM EDT

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the…

Jon C. Ogg | Jun 6, 2013 at 8:00 AM EDT

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum…

Jon C. Ogg | May 14, 2013 at 7:50 AM EDT

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own…

Paul Ausick | Apr 26, 2013 at 8:30 AM EDT

AbbVie Reports First Earnings Since IPO

ThinkstockAbbVie Inc. (NYSE: ABBV) reported first-quarter 2013 results before markets opened this morning. The pharmaceutical research firm posted adjusted diluted…

Paul Ausick | Apr 22, 2013 at 4:03 PM EDT

24/7 Wall St. Closing Bell — April 22, 2013: Markets Close Higher After Rocky Start

U.S. equity markets opened higher this morning, but struggled to stay in positive territory for most of the morning. There…

Jon C. Ogg | Apr 22, 2013 at 8:15 AM EDT

Top Analyst Upgrades and Positive Views from Wall Street

Investors and traders are on the lookout for fresh research ideas from Wall St. that will lead to higher income…

Jon C. Ogg | Apr 11, 2013 at 8:20 AM EDT

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and…

1 … 38 39 40 41

AbbVie : ABBV

All AbbVie Articles

Five Quantitative Analyst Stocks With Limited Emerging Markets Exposure

Many Key Changes to Goldman Sachs Conviction Buy List for 2014

Goldman Sachs Makes Major Conviction Buy List Changes for 2014

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More

Top Analyst Upgrades and Downgrades: Apple, BBVA, Kors, PotBelly and More

New IPO ETF Certain to Gain Traction, More IPO ETF Competition

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

AbbVie Reports First Earnings Since IPO

24/7 Wall St. Closing Bell — April 22, 2013: Markets Close Higher After Rocky Start

Top Analyst Upgrades and Positive Views from Wall Street

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

AI XRP Price Prediction: Claude Fable 5 Predicts the XRP Price for End of 2026

The Monthly Income Trap: How JEPQ Investors Gave Up $18,000 Per $10,000 Invested Since Inception

‘The Borrower Is Slave to the Lender’: Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

'The Borrower Is Slave to the Lender': Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

$1 Million in Retirement Savings Spends Like $40,000 a Year. Here's Why That's Not Enough.

AI XRP Price Prediction: Claude Fable 5 Predicts the XRP Price for End of 2026

The Monthly Income Trap: How JEPQ Investors Gave Up $18,000 Per $10,000 Invested Since Inception

AbbVie : ABBV

All AbbVie Articles

Five Quantitative Analyst Stocks With Limited Emerging Markets Exposure

Many Key Changes to Goldman Sachs Conviction Buy List for 2014

Goldman Sachs Makes Major Conviction Buy List Changes for 2014

Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More

Top Analyst Upgrades and Downgrades: Apple, BBVA, Kors, PotBelly and More

New IPO ETF Certain to Gain Traction, More IPO ETF Competition

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Jefferies Raises Price Targets on Pharmaceutical Stocks to Buy

Merrill Lynch Large Cap Pharmaceutical Stocks to Buy

AbbVie Reports First Earnings Since IPO

24/7 Wall St. Closing Bell — April 22, 2013: Markets Close Higher After Rocky Start

Top Analyst Upgrades and Positive Views from Wall Street

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

AI XRP Price Prediction: Claude Fable 5 Predicts the XRP Price for End of 2026

The Monthly Income Trap: How JEPQ Investors Gave Up $18,000 Per $10,000 Invested Since Inception

‘The Borrower Is Slave to the Lender’: Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

Featured Reads

'The Borrower Is Slave to the Lender': Dave Ramsey Warns a 22-Year-Old Against Letting a Rich Friend Pay Off His $70,000 Debt

$1 Million in Retirement Savings Spends Like $40,000 a Year. Here's Why That's Not Enough.